The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Cerebellar Mass Resection on Pain Processing
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Impact of Radiation Therapy on Breast Conservation in DCIS
- Status
- COMPLETED
- Phase
- N/A
A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus for Cancer With TSC1 or TSC2 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance
- Status
- COMPLETED
- Phase
- N/A
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Healthy Directions After Lung Surgery Pilot
- Status
- COMPLETED
- Phase
- NA